[1] Dessein A,Chevillard C,Arnaud V,et al. Variants of CTGF are associated with hepatic fibrosis in Chinese,Sudanese,and Brazilians infected with schistosomes. J Exp Med,2009,206(11):2321-2328. [2] Kodama T,Takehara T,Hikita H,et al. Increases in p53 expression induce CTGF synthesis by mouse and human hepatocytes and result in liver fibrosis in mice. Clin Invest, 2011,Jul 11. pii: 44957. doi:10.1172/JCI44957. [3] Tong Z,Chen R,Alt DS,et al. Susceptibility to liver fibrosis in mice expressing a connective tissue growth factor transgene in hepatocytes. Hepatology,2009,50(3),939-947. [4] 彭梅娟, 郝春秋,白雪帆,等. 介导大鼠结缔组织生长因子基因沉默的慢病毒载体转移质粒的构建及鉴定.生物技术通讯,2008,9(3):350-352. [5] Hayashi N,Kakimuma T,Soma Y,et al. Connective tissue growth factor is directly related to liver fibrosis.Hepatogastroenterology,2002,49(43):133-135. [6] Wang X,Chen Y,Ren J,et.al. Small interfering RNA for effective cancer therapies.Mini Rev Med Chem,2011,11(2):114-124. [7] 郭丽梅,林梅,陆珊,等. 一次性大剂量二甲基亚硝胺致大鼠肝纤维化模型中肝星状细胞的病理变化.实用肝脏病杂志, 2009,8(12):244-247. [8] Brew K,Dinakarpandian D,Nagase H. Tissue inhibitors of metalloproteinases:evolution,structure and function. Biochim Biophys Acta,2000,1477(1-2):267-283. [9] Yoshiji H,Kuriyama S,Miyamoto Y,et al. Tissue inhibitor of metalloproteinases-1 promotes liver fibrosis development in a transgenic mouse model. Hepatology,2000,32(6):1248-1254. [10] Lotersztajn S,Julien B,Teixeira-Clerc F,et al. Hepatic fibrosis: molecular mechanisms and drug targets.Annu Rev Pharmacol Toxicol,2005,45:605-628. [11] 蒋玉凤,黄飞,张建军,等. 结缔组织生长因子和金属蛋白酶组织抑制因子-1RNA干扰靶位的筛选. 实用肝脏病杂志, 2011,8(14):246-248. |